Company Search:
Advanced Search
Sponsored Links
Stemline Therapeutics Inc Company Snapshot
Stemline Therapeutics Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Stemline Therapeutics Inc with three other companies in this sector in the United States: Ibio, Incorporation (2016 sales of $948,000.00 ), Prothena Corporation PLC ($1.06 million of which 100% was Pharmaceuticals), and Steadymed Ltd ($1.07 million ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Stemline Therapeutics Inc
  Stock Performance Chart for Stemline Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (12/8/2017): 14.85
(Figures in U.S. Dollars)
1 Week -4.5%   13 Weeks 6.1%  
4 Weeks 54.7%   52 Weeks 10.0%  
Stemline Therapeutics Inc Key Data:
  Ticker: STML Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 1,041,354
(Year Ending Jan 2017).
Employees: 29
  Currency: U.S. Dollars Market Cap: 375,510,569
  Fiscal Yr Ends: December Shares Outstanding: 25,286,907
  Share Type: Common Closely Held Shares: 2,806,087
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.